(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP4A1 mRNA] CTD PMID:31150632 1-benzylpiperazine decreases expression EXP 6480464 N-benzylpiperazine results in decreased expression of CYP4A1 mRNA CTD PMID:26821219 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP4A1 mRNA CTD PMID:30723492 2,2',4,4'-Tetrabromodiphenyl ether increases expression EXP 6480464 2 more ... CTD PMID:20056577 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP4A1 mRNA CTD PMID:19969063 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP4A1 mRNA CTD PMID:32387183 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CYP4A22 mRNA CTD PMID:21346803 2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid increases expression EXP 6480464 Nafenopin results in increased expression of CYP4A1 mRNA CTD PMID:18079279 , PMID:19647067 2-methyl-2-[4-(1,2,3,4-tetrahydronaphthalen-1-yl)phenoxy]propanoic acid multiple interactions EXP 6480464 Okadaic Acid inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA], tautomycin inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA] CTD PMID:18079279 20-HETE multiple interactions EXP 6480464 20-hydroxy-5 more ... CTD PMID:11124159 , PMID:12388396 20-HETE increases chemical synthesis EXP 6480464 CYP4A1 protein results in increased chemical synthesis of 20-hydroxy-5 more ... CTD PMID:11124159 3-phenoxybenzoic acid increases expression EXP 6480464 3-phenoxybenzoic acid results in increased expression of CYP4A1 mRNA CTD PMID:32040184 4-tert-Octylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of CYP4A22 mRNA CTD PMID:17011747 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CYP4A1 mRNA CTD PMID:24780913 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of CYP4A1 mRNA CTD PMID:12883083 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP4A1 mRNA CTD PMID:16483693 aristolochic acid A increases expression ISO RGD:1603864 6480464 aristolochic acid I results in increased expression of CYP4A22 mRNA CTD PMID:33212167 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CYP4A1 mRNA CTD PMID:8471063 Aroclor 1254 increases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP4A1 mRNA, Chlorodiphenyl (54% Chlorine) results in increased expression of CYP4A1 protein CTD PMID:11163329 , PMID:8471063 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA CTD PMID:33854195 barium sulfate increases expression EXP 6480464 Barium Sulfate results in increased expression of CYP4A1 mRNA CTD PMID:11124224 benoxaprofen increases expression EXP 6480464 benoxaprofen results in increased expression of CYP4A1 protein CTD PMID:2069584 benzene increases expression EXP 6480464 Benzene results in increased expression of CYP4A1 protein CTD PMID:8620572 benzo[a]pyrene increases methylation ISO RGD:1603864 6480464 Benzo(a)pyrene results in increased methylation of CYP4A22 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1603864 6480464 Benzo(a)pyrene results in decreased expression of CYP4A22 mRNA CTD PMID:32234424 beta-naphthoflavone increases expression EXP 6480464 beta-Naphthoflavone results in increased expression of CYP4A1 mRNA CTD PMID:19969063 bexarotene increases expression EXP 6480464 bexarotene results in increased expression of CYP4A22 mRNA CTD PMID:16648578 bezafibrate increases expression EXP 6480464 Bezafibrate results in increased expression of CYP4A1 mRNA CTD PMID:19647067 bezafibrate multiple interactions EXP 6480464 Acetylcysteine promotes the reaction [Bezafibrate results in increased expression of CYP4A1 mRNA] CTD PMID:19647067 bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of CYP4A1, Diethylhexyl Phthalate results in increased expression of CYP4A1 mRNA CTD PMID:16954067 more ... bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CYP4A1 mRNA, bisphenol A affects the expression of CYP4A22 mRNA CTD PMID:25181051 , PMID:30903817 bisphenol A decreases methylation ISO RGD:1603864 6480464 bisphenol A results in decreased methylation of CYP4A22 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP4A1 mRNA CTD PMID:32145629 buspirone increases expression EXP 6480464 Buspirone results in increased expression of CYP4A1 mRNA CTD PMID:24136188 carbamazepine decreases expression EXP 6480464 Carbamazepine results in decreased expression of CYP4A1 mRNA CTD PMID:17381134 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA CTD PMID:33854195 ciprofibrate increases activity EXP 6480464 ciprofibrate results in increased activity of CYP4A1 protein CTD PMID:7676460 ciprofibrate increases expression EXP 6480464 ciprofibrate results in increased expression of CYP4A1 mRNA, ciprofibrate results in increased expression of CYP4A1 protein CTD PMID:19647067 more ... climbazole increases expression EXP 6480464 climbazole results in increased expression of CYP4A1 protein CTD PMID:11552297 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of CYP4A1 mRNA CTD PMID:18246545 clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of CYP4A1 mRNA more ... CTD PMID:10476907 more ... clofibrate multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibrate] results in increased expression of CYP4A1 protein, Clofibrate inhibits the reaction [H2AZ1 protein binds to CYP4A1 gene] CTD PMID:10550479 , PMID:28495587 clofibric acid multiple interactions EXP 6480464 Clofibric Acid results in increased expression of and results in increased activity of CYP4A1 protein CTD PMID:15946133 clofibric acid increases expression EXP 6480464 Clofibric Acid results in increased expression of CYP4A1 mRNA CTD PMID:15670589 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of CYP4A1 mRNA CTD PMID:24386269 copper atom multiple interactions EXP 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA, gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA] CTD PMID:25813056 copper(0) multiple interactions EXP 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA, gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA] CTD PMID:25813056 cortisol increases expression EXP 6480464 Hydrocortisone results in increased expression of CYP4A1 mRNA CTD PMID:10476907 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of CYP4A22 mRNA CTD PMID:19224547 cyhalothrin increases expression EXP 6480464 cyhalothrin results in increased expression of CYP4A1 mRNA CTD PMID:29727961 dehydroepiandrosterone multiple interactions EXP 6480464 Okadaic Acid inhibits the reaction [Dehydroepiandrosterone results in increased expression of CYP4A1 mRNA] CTD PMID:18079279 dehydroepiandrosterone increases expression EXP 6480464 Dehydroepiandrosterone results in increased expression of CYP4A1 mRNA CTD PMID:18079279 , PMID:8700121 dehydroepiandrosterone sulfate increases expression EXP 6480464 Dehydroepiandrosterone Sulfate results in increased expression of CYP4A1 mRNA, Dehydroepiandrosterone Sulfate results in increased expression of CYP4A1 protein CTD PMID:25786523 , PMID:8700121 dehydroepiandrosterone sulfate multiple interactions EXP 6480464 [Dehydroepiandrosterone Sulfate co-treated with Phenobarbital] results in increased expression of CYP4A1 protein CTD PMID:25786523 deoxycholic acid decreases expression EXP 6480464 Deoxycholic Acid results in decreased expression of CYP4A1 protein CTD PMID:10453939 deoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in decreased expression of CYP4A1 protein] CTD PMID:10453939 Diallyl sulfide decreases expression EXP 6480464 allyl sulfide results in decreased expression of CYP4A1 protein CTD PMID:20116195 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CYP4A1 mRNA, Dibutyl Phthalate results in increased expression of CYP4A1 protein CTD PMID:15901914 diethyl phthalate increases expression EXP 6480464 diethyl phthalate results in increased expression of CYP4A1 protein CTD PMID:16641546 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CYP4A22 mRNA CTD PMID:17011747 diquat increases expression EXP 6480464 Diquat results in increased expression of CYP4A1 mRNA CTD PMID:7676460 dodecanoic acid affects metabolic processing EXP 6480464 CYP4A1 protein affects the metabolism of lauric acid CTD PMID:15879494 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of CYP4A1 mRNA, Doxorubicin results in increased expression of CYP4A1 protein CTD PMID:19796650 ethanol multiple interactions EXP 6480464 [Ethanol co-treated with Dietary Fats] results in increased expression of CYP4A1 mRNA more ... CTD PMID:20116195 more ... ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of CYP4A1 mRNA CTD PMID:26854922 ethanol increases expression EXP 6480464 Ethanol results in increased expression of CYP4A1 protein CTD PMID:20116195 farnesol increases activity EXP 6480464 Farnesol results in increased activity of CYP4A1 protein CTD PMID:15840382 felbamate decreases expression EXP 6480464 felbamate results in decreased expression of CYP4A1 mRNA CTD PMID:17381134 fenofibrate affects expression EXP 6480464 Fenofibrate affects the expression of CYP4A1 mRNA CTD PMID:20801182 fenofibrate increases expression ISO RGD:1603864 6480464 Fenofibrate results in increased expression of CYP4A22 mRNA CTD PMID:25572481 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of CYP4A1 mRNA CTD PMID:17264098 more ... fenofibrate multiple interactions EXP 6480464 [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of CYP4A1 mRNA CTD PMID:18775883 fenvalerate increases activity EXP 6480464 fenvalerate metabolite results in increased activity of CYP4A22 protein CTD PMID:10630566 fenvalerate increases expression EXP 6480464 fenvalerate metabolite results in increased expression of CYP4A22 protein CTD PMID:10630566 fipronil decreases expression EXP 6480464 fipronil results in decreased expression of CYP4A1 mRNA CTD PMID:23962444 fipronil decreases expression ISO RGD:1603864 6480464 fipronil results in decreased expression of CYP4A22 mRNA CTD PMID:27091632 fipronil multiple interactions ISO RGD:1603864 6480464 [fipronil co-treated with DEET] results in decreased expression of CYP4A22 mRNA CTD PMID:27091632 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CYP4A1 mRNA CTD PMID:24136188 fomepizole multiple interactions EXP 6480464 fomepizole promotes the reaction [Ethanol results in increased expression of CYP4A1 protein] CTD PMID:20116195 fomepizole increases expression EXP 6480464 fomepizole results in increased expression of CYP4A1 protein CTD PMID:20116195 fructose multiple interactions EXP 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA, gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA] CTD PMID:25813056 furan decreases expression EXP 6480464 furan results in decreased expression of CYP4A1 mRNA CTD PMID:15120968 , PMID:26194646 gabapentin decreases expression EXP 6480464 gabapentin results in decreased expression of CYP4A1 mRNA CTD PMID:17381134 gadolinium trichloride multiple interactions EXP 6480464 gadolinium chloride promotes the reaction [[Fructose co-treated with Copper deficiency] results in decreased expression of CYP4A1 mRNA] CTD PMID:25813056 gemfibrozil increases expression EXP 6480464 Gemfibrozil results in increased expression of CYP4A1 mRNA CTD PMID:27665778 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of CYP4A1 mRNA CTD PMID:24136188 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA CTD PMID:33854195 GW 6471 multiple interactions EXP 6480464 perfluorododecanoic acid inhibits the reaction [GW 6471 results in decreased expression of CYP4A1 mRNA] CTD PMID:26168851 GW 6471 decreases expression EXP 6480464 GW 6471 results in decreased expression of CYP4A1 mRNA CTD PMID:26168851 GW 7647 increases expression EXP 6480464 GW 7647 results in increased expression of CYP4A1 mRNA CTD PMID:23315828 Heliotrine decreases expression ISO RGD:1603864 6480464 heliotrine results in decreased expression of CYP4A22 mRNA CTD PMID:26100227 hexadecanoic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid co-treated with Ethanol] results in decreased expression of CYP4A1 mRNA CTD PMID:26854922 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA CTD PMID:33854195 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP4A1 mRNA CTD PMID:22129741 kojic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in decreased expression of CYP4A22 mRNA, [Diethylnitrosamine co-treated with kojic acid] results in increased expression of CYP4A22 mRNA CTD PMID:18544905 lansoprazole increases expression EXP 6480464 Lansoprazole results in increased expression of CYP4A1 protein CTD PMID:9152597 lead nitrate increases expression EXP 6480464 lead nitrate results in increased expression of CYP4A1 mRNA CTD PMID:23391631 leflunomide increases expression EXP 6480464 leflunomide results in increased expression of CYP4A1 mRNA CTD PMID:24136188 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of CYP4A1 mRNA CTD PMID:15120968 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of CYP4A1 mRNA CTD PMID:15120968 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CYP4A1 mRNA CTD PMID:21515302 N,N-diethyl-m-toluamide decreases expression ISO RGD:1603864 6480464 DEET results in decreased expression of CYP4A22 mRNA CTD PMID:27091632 N,N-diethyl-m-toluamide multiple interactions ISO RGD:1603864 6480464 [fipronil co-treated with DEET] results in decreased expression of CYP4A22 mRNA CTD PMID:27091632 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of CYP4A1 mRNA, Acetylcysteine promotes the reaction [Bezafibrate results in increased expression of CYP4A1 mRNA] CTD PMID:19647067 , PMID:22129741 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibrate] results in increased expression of CYP4A1 protein more ... CTD PMID:10550479 more ... nafenopin multiple interactions EXP 6480464 Okadaic Acid inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA], tautomycin inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA] CTD PMID:18079279 nafenopin increases expression EXP 6480464 Nafenopin results in increased expression of CYP4A1 mRNA CTD PMID:18079279 , PMID:19647067 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of CYP4A1 mRNA CTD PMID:24136188 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of CYP4A1 mRNA CTD PMID:24136188 O-methyleugenol decreases expression ISO RGD:1603864 6480464 methyleugenol results in decreased expression of CYP4A22 mRNA CTD PMID:32234424 okadaic acid multiple interactions EXP 6480464 Okadaic Acid inhibits the reaction [Dehydroepiandrosterone results in increased expression of CYP4A1 mRNA], Okadaic Acid inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA] CTD PMID:18079279 oleic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid co-treated with Ethanol] results in decreased expression of CYP4A1 mRNA CTD PMID:26854922 orotic acid multiple interactions EXP 6480464 [Sucrose co-treated with Orotic Acid] results in increased expression of CYP4A1 mRNA CTD PMID:15670589 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of CYP4A1 mRNA CTD PMID:23665939 p-tert-Amylphenol increases expression EXP 6480464 4-tert-octylphenol results in increased expression of CYP4A22 mRNA CTD PMID:17011747 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of CYP4A22 mRNA CTD PMID:15585946 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CYP4A1 mRNA CTD PMID:18246545 , PMID:32479839 pent-4-enoic acid increases expression EXP 6480464 4-pentenoic acid results in increased expression of CYP4A1 mRNA CTD PMID:12883083 perfluorobutyric acid increases expression EXP 6480464 perfluorobutyric acid analog results in increased expression of CYP4A1 mRNA, perfluorobutyric acid results in increased expression of CYP4A1 mRNA CTD PMID:19407336 , PMID:21878386 perfluorododecanoic acid multiple interactions EXP 6480464 perfluorododecanoic acid inhibits the reaction [GW 6471 results in decreased expression of CYP4A1 mRNA], perfluorododecanoic acid inhibits the reaction [pirinixic acid results in increased expression of CYP4A1 mRNA] CTD PMID:26168851 perfluorododecanoic acid increases expression EXP 6480464 perfluorododecanoic acid results in increased expression of CYP4A1 mRNA CTD PMID:26168851 perfluorohexanoic acid increases expression EXP 6480464 perfluorohexanoic acid results in increased expression of CYP4A1 mRNA CTD PMID:19407336 perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid analog results in increased expression of CYP4A1 protein more ... CTD PMID:18923995 more ... perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1603864 6480464 perfluorooctane sulfonic acid results in decreased expression of CYP4A22 mRNA CTD PMID:32790152 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1603864 6480464 perfluorooctane sulfonic acid results in increased expression of CYP4A22 mRNA CTD PMID:27153767 perfluorooctanoic acid increases activity EXP 6480464 perfluorooctanoic acid results in increased activity of CYP4A1 protein CTD PMID:8011682 perfluorooctanoic acid decreases expression ISO RGD:1603864 6480464 perfluorooctanoic acid results in decreased expression of CYP4A22 mRNA CTD PMID:32790152 perfluorooctanoic acid increases expression ISO RGD:1603864 6480464 perfluorooctanoic acid results in increased expression of CYP4A1 mRNA, perfluorooctanoic acid results in increased expression of CYP4A22 mRNA CTD PMID:21723365 more ... perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of CYP4A1 mRNA, perfluorooctanoic acid results in increased expression of CYP4A1 protein CTD PMID:19162173 more ... phenformin increases expression EXP 6480464 Phenformin results in increased expression of CYP4A1 mRNA CTD PMID:31324951 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CYP4A1 mRNA CTD PMID:19162173 phenobarbital multiple interactions EXP 6480464 [Dehydroepiandrosterone Sulfate co-treated with Phenobarbital] results in increased expression of CYP4A1 protein CTD PMID:25786523 phenobarbital decreases expression EXP 6480464 Phenobarbital results in decreased expression of CYP4A1 mRNA CTD PMID:12883083 more ... phenobarbital increases expression EXP 6480464 Phenobarbital results in increased expression of CYP4A1 protein CTD PMID:9152597 phenylephrine multiple interactions EXP 6480464 20-hydroxy-5 more ... CTD PMID:11124159 , PMID:12388396 phenylephrine increases response to substance EXP 6480464 CYP4A1 protein results in increased susceptibility to Phenylephrine CTD PMID:12388396 phenylephrine affects response to substance EXP 6480464 CYP4A1 protein affects the susceptibility to Phenylephrine CTD PMID:11124159 phenytoin decreases expression EXP 6480464 Phenytoin results in decreased expression of CYP4A1 mRNA CTD PMID:17381134 pirinixic acid multiple interactions EXP 6480464 [pirinixic acid results in increased activity of PPARA protein] which results in increased expression of CYP4A1 mRNA more ... CTD PMID:19103650 , PMID:26168851 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CYP4A1 mRNA, pirinixic acid results in increased expression of CYP4A1 protein CTD PMID:15635043 more ... pravastatin decreases expression EXP 6480464 Pravastatin results in decreased expression of CYP4A1 mRNA CTD PMID:27225895 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of CYP4A1 mRNA CTD PMID:19162173 , PMID:29548889 propyzamide increases expression EXP 6480464 pronamide results in increased expression of CYP4A1 mRNA CTD PMID:25846364 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in decreased expression of CYP4A1 mRNA CTD PMID:25905778 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CYP4A1 mRNA CTD PMID:28374803 Senkirkine decreases expression ISO RGD:1603864 6480464 senkirkine results in decreased expression of CYP4A22 mRNA CTD PMID:26100227 simazine increases expression EXP 6480464 Simazine results in increased expression of CYP4A22 protein CTD PMID:9711812 simazine increases activity EXP 6480464 Simazine results in increased activity of CYP4A22 protein CTD PMID:9711812 soybean oil affects expression EXP 6480464 Soybean Oil affects the expression of CYP4A1 mRNA CTD PMID:16079505 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of CYP4A1 mRNA CTD PMID:25905778 streptozocin multiple interactions EXP 6480464 [Dietary Fats co-treated with Streptozocin] results in increased expression of CYP4A1 mRNA more ... CTD PMID:24815820 , PMID:25905778 sucrose multiple interactions EXP 6480464 [Sucrose co-treated with Orotic Acid] results in increased expression of CYP4A1 mRNA CTD PMID:15670589 Sudan III decreases expression EXP 6480464 sudan III results in decreased expression of CYP4A1 mRNA CTD PMID:15585952 sunitinib increases expression EXP 6480464 sunitinib results in increased expression of CYP4A1 mRNA CTD PMID:26797788 tamoxifen decreases expression EXP 6480464 Tamoxifen results in decreased expression of CYP4A22 mRNA CTD PMID:19224547 Tautomycin multiple interactions EXP 6480464 tautomycin inhibits the reaction [Nafenopin results in increased expression of CYP4A1 mRNA] CTD PMID:18079279 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CYP4A1 mRNA CTD PMID:21515302 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of CYP4A1 mRNA] CTD PMID:31150632 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP4A1 mRNA CTD PMID:31150632 tetracycline increases expression EXP 6480464 Tetracycline results in increased expression of CYP4A1 mRNA CTD PMID:12883083 tetracycline decreases expression EXP 6480464 Tetracycline results in decreased expression of CYP4A22 mRNA CTD PMID:19224547 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA CTD PMID:33854195 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP4A1 mRNA CTD PMID:34492290 toluene increases expression EXP 6480464 Toluene results in increased expression of CYP4A1 protein CTD PMID:8620572 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CYP4A1 mRNA, Trichloroethylene results in increased expression of CYP4A1 protein CTD PMID:19448997 , PMID:8620572 triphenyl phosphate decreases expression EXP 6480464 triphenyl phosphate results in decreased expression of CYP4A1 mRNA CTD PMID:30589522 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP4A1 mRNA CTD PMID:21515302 ursodeoxycholic acid multiple interactions EXP 6480464 Ursodeoxycholic Acid inhibits the reaction [Deoxycholic Acid results in decreased expression of CYP4A1 protein] CTD PMID:10453939 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of CYP4A1 mRNA CTD PMID:17381134 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CYP4A1 mRNA, Valproic Acid results in increased expression of CYP4A22 mRNA CTD PMID:19224547 , PMID:19850644 zaragozic acid A increases expression EXP 6480464 squalestatin 1 results in increased expression of CYP4A1 mRNA CTD PMID:27225895
